科兴制药(688136.SH)：相关管理层累计增持1308.85万元公司股份

格隆汇资讯07-30 18:01

格隆汇7月30日丨科兴制药(688136.SH)公布，截至2024年7月30日，增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股，占公司总股本的0.49%，合计增持金额为人民币1,308.85万元，已超过本次增持计划下限金额，本次增持计划届满且已实施完毕。增持主体：公司实际控制人兼董事长邓学勤先生，董事、总经理赵彦轻先生，董事、董事会秘书兼财务总监王小琴女士，董事、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2455866829?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-30 18:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2455866829","market":"sh","top_or_hot":-1,"title":"科兴制药(688136.SH)：相关管理层累计增持1308.85万元公司股份","media":"格隆汇资讯","content":"<div>\n<p>格隆汇7月30日丨科兴制药(688136.SH)公布，截至2024年7月30日，增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股，占公司总股本的0.49%，合计增持金额为人民币1,308.85万元，已超过本次增持计划下限金额，本次增持计划届满且已实施完毕。增持主体：公司实际控制人兼董事长邓学勤先生，董事、总经理赵彦轻先生，董事、董事会秘书兼财务总监王小琴女士，董事、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科兴制药(688136.SH)：相关管理层累计增持1308.85万元公司股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科兴制药(688136.SH)：相关管理层累计增持1308.85万元公司股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-30 18:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇7月30日丨科兴制药(688136.SH)公布，截至2024年7月30日，增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股，占公司总股本的0.49%，合计增持金额为人民币1,308.85万元，已超过本次增持计划下限金额，本次增持计划届满且已实施完毕。增持主体：公司实际控制人兼董事长邓学勤先生，董事、总经理赵彦轻先生，董事、董事会秘书兼财务总监王小琴女士，董事、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b","article_id":"2455866829","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2455866829","pubTimestamp":1722333673,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇7月30日丨科兴制药(688136.SH)公布，截至2024年7月30日，增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股，占公司总股本的0.49%，合计增持金额为人民币1,308.85万元，已超过本次增持计划下限金额，本次增持计划届满且已实施完毕。增持主体：公司实际控制人兼董事长邓学勤先生，董事、总经理赵彦轻先生，董事、董事会秘书兼财务总监王小琴女士，董事、副总经理崔宁女士以及副总经理邵珂先生、马鸿杰女士。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688136":"科兴制药","BK0239":"医药制造"},"translate_title":"Sinovac Pharmaceutical (688136. SH): Relevant management has increased its holdings of company shares by 13.0885 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688136":1},"content_text":"格隆汇7月30日丨科兴制药(688136.SH)公布，截至2024年7月30日，增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股，占公司总股本的0.49%，合计增持金额为人民币1,308.85万元，已超过本次增持计划下限金额，本次增持计划届满且已实施完毕。增持主体：公司实际控制人兼董事长邓学勤先生，董事、总经理赵彦轻先生，董事、董事会秘书兼财务总监王小琴女士，董事、副总经理崔宁女士以及副总经理邵珂先生、马鸿杰女士。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2455866829"}